Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

Could Dynamic Duo Diageo plc And GlaxoSmithKline plc Make You A Millionaire?

GlaxoSmithKline plc (LON: GSK) and Diageo plc (LON: DGE) are the perfect shares to get rich slowly.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The £1m mark is a key goal for many investors and the most effective way to hit this target is slowly, without taking excessive risks. Personally, I think the best investments to help you do this are GlaxoSmithKline (LSE: GSK) and Diageo (LSE: DGE). 

Glaxo and Diageo won’t run you into Warren Buffett overnight, but they will help you meet your savings goals. Indeed, his first rule of investing is “don’t lose money”, the second rule is “don’t forget rule one”. Losing money can be extremely damaging to you investment returns and even a small 10% loss can hold you back for years.

And neither Glaxo nor Diageo will cost you money. Their shares may fall in the short term but over the long term they should push steadily higher.

Defensive companies

You see, Diageo and Glaxo are defensive companies. Diageo is the world’s largest alcoholic beverage company, with some of the world’s bestselling spirit brands in its drinks cabinet. Meanwhile, Glaxo is a leading pharmaceutical company, which manufactures a broad selection of every day treatments and consumer goods that have become consumer staples over the years.

So, Diageo and Glaxo are not going to go out of business any time and it’s highly unlikely that either company will see its share price go to zero. 

With this being the case, investors can buy and hold the two companies’ shares in their portfolios over the long term without much worry. What’s more, both Glaxo and Diageo have a history of returning the majority of their earnings to investors in the form of dividends. Through the power of compounding, these cash returns have helped accelerate total returns achieved from the investments.

The power of compounding

If you invested £1,000 in Diageo during 1995, with dividends invested that stake would be worth £5,200 today, an average annual return of 10.10%. Similarly, if you’d purchased £1,000 of Glaxo stock during 1995, that stake would be worth £4,412 today, after achieving an average annual return of 7.9%. 

These figures may not seem like much at first glance, but for the long-term investor the returns really start to add up. Over four decades, a £1,000 investment in Glaxo, made during 1995 will be worth around £23,000 by 2035. However, the Diageo investment would worth a staggering £55,000 by 2035.

If you were to invest £1,000 in each company and add an additional £1,000 to each holding every year, based on the above rate of growth, your portfolio would be worth just under £1m by 2035.

Based on these numbers then, Glaxo and Diageo could make you a millionaire. 

Glaxo currently trades at a forward P/E of 17.3, which seems expensive but the company trades at a discount of about 10% to its international peers. The company’s shares offer a yield of 4.9%. Diageo currently trades at a forward P/E of 20.4, in line with its international peers and the company offers a dividend yield of 2.6%. 

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Two employees sat at desk welcoming customer to a Tesla car showroom
Investing Articles

Here’s what a single share of Tesla stock cost in January – and what it’s worth now!

Tesla stock's moved up this year -- and it's had a wild ride along the way. Christopher Ruane explains why…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Rolls-Royce shares have done it again in 2025! But could the party be over?

2025's been another storming year for Rolls-Royce shares -- and this writer missed out! Might it still be worth him…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

Is this the last chance to buy these FTSE 100 shares on the cheap?

Diageo and Barratt Redrow's share prices have tanked. Is this the opportunity investors seeking cheap FTSE 100 shares have been…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

Legal & General shares yield a staggering 8.7% – will they shower investors with income in 2026?

Legal & General shares pay the highest dividend yield on the entire FTSE 100. Harvey Jones asks whether there is…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

With its 16% dividend yield, is it time for me to buy this FTSE 250 passive income star?

Ithaca Energy’s 16% dividend yield looks irresistible -- but with tax headwinds still blowing strong, can this FTSE 250 passive…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

Under £27 now, Shell’s share price looks a huge bargain – here’s why

Shell’s share price is at a major discount to its peers, but Simon Watkins believes it won’t do so for…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

Would I be mad to buy more Diageo shares near £16?

Edward Sheldon owns Diageo shares in his ISA and he's sitting on an ugly loss after the recent share price…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Growth Shares

Down 60% since 2022: can Diageo’s share price ever stage a turnaround?

Diageo’s share price has plunged, but with its premium brands, strong cash flows, and a solid dividend yield, can it…

Read more »